Breaking News Instant updates and real-time market news.

CRI

Carter's

$75.71 /

+0.665 (+0.89%)

06:20
05/05/20
05/05
06:20
05/05/20
06:20

Carter's board suspends quarterly dividend

  • 05

    May

  • 14

    May

CRI Carter's
$75.71 /

+0.665 (+0.89%)

04/20/20 Deutsche Bank
Carter's price target lowered to $78 from $95 at Deutsche Bank
10/24/19 CFRA
Carter's upgraded to Buy from Hold at CFRA
10/02/19
Fly Intel: Top five analyst upgrades
10/02/19
Carter's upgraded to Buy from Neutral at DA Davidson

TODAY'S FREE FLY STORIES

General news
FX Update: The dollar and yen have remained weak » 03:20
05/28/20
05/28
03:20
05/28/20
03:20

FX Update: The dollar and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Tetraphase discloses revised $34M Melinta proposal superior to AcelRx » 21:00
05/27/20
05/27
21:00
05/27/20
21:00
ACRX

AcelRx

$1.55 /

-0.095 (-5.78%)

, TTPH

Tetraphase

$2.20 /

-0.2 (-8.33%)

Tetraphase (TTPH)…

Tetraphase (TTPH) announced that its board has received a revised proposal from Melinta Therapeutics amending its prior proposal to acquire the company and has determined that the amended Melinta Proposal is a "Superior Offer" under the terms of the Agreement and Plan of Merge to which the company is a party with AcelRx Pharmaceuticals (ACRX) and its merger subsidiary. In connection with this determination and in accordance with the terms of the AcelRx Merger Agreement, the company has given notice to AcelRx of the Amended Melinta Proosal, the Superior Offer determination and of its intention to consider changing its recommendation of the AcelRx Merger Agreement or terminating the AcelRx Merger Agreement unless AcelRx proposes revisions to the terms of the AcelRx Merger Agreement or makes another proposal on or prior to Monday, June 1, 2020. Under the Amended Proposal, Melinta has offered to acquire Tetraphase for $34.0M in cash, plus an additional $16.0M in cash potentially payable under contingent value rights to be issued in the proposed acquisition. Under the Amended Melinta Proposal, the upfront cash consideration would be as follows: (i) $1.52 per share of Tetraphase common stock, (ii) $2.21 per share of Tetraphase common stock underlying the common stock warrants issued by the company in 2019, and (iii) $2.21 per share of Tetraphase common stock underlying the common stock warrants issued by the company in 2020. In addition, the Amended Melinta Proposal does not provide for a downward adjustment based on the company's closing net cash amount.

ShowHide Related Items >><<
ACRX AcelRx
$1.55 /

-0.095 (-5.78%)

ACRX AcelRx
$1.55 /

-0.095 (-5.78%)

05/07/20 Gabelli
Tetraphase upgraded to Hold from Sell at Gabelli
03/17/20 H.C. Wainwright
AcelRx price target lowered to $7 from $9 at H.C. Wainwright
03/17/20 Gabelli
Tetraphase downgraded to Sell from Hold at Gabelli
11/11/19 Credit Suisse
Credit Suisse downgrades AcelRx to Neutral, cuts target to $2 from $7
TTPH Tetraphase
$2.20 /

-0.2 (-8.33%)

01/24/20 Gabelli
Tetraphase downgraded to Hold on fundraising dilution at Gabelli
ACRX AcelRx
$1.55 /

-0.095 (-5.78%)

ACRX AcelRx
$1.55 /

-0.095 (-5.78%)

TTPH Tetraphase
$2.20 /

-0.2 (-8.33%)

Initiation
TreeHouse initiated with a Buy at DA Davidson » 20:48
05/27/20
05/27
20:48
05/27/20
20:48
THS

TreeHouse

$51.62 /

+0.205 (+0.40%)

DA Davidson analyst Brian…

DA Davidson analyst Brian Holland initiated coverage of TreeHouse with a Buy rating and $62 price target. The company's mix is net favorable amid the COVID-19 pandemic as its retail grocery channel comprises about 80% of the company's total net sales, the analyst tells investors in a research note, noting that as the economy moves into recession, consumption of food at home should remain in favor.

ShowHide Related Items >><<
THS TreeHouse
$51.62 /

+0.205 (+0.40%)

THS TreeHouse
$51.62 /

+0.205 (+0.40%)

05/27/20 DA Davidson
TreeHouse initiated with a Buy at DA Davidson
05/08/20 SunTrust
TreeHouse price target raised to $55 from $50 at SunTrust
04/16/20
Fly Intel: Top five analyst upgrades
04/16/20 Credit Suisse
TreeHouse upgraded to Outperform from Neutral at Credit Suisse
THS TreeHouse
$51.62 /

+0.205 (+0.40%)

THS TreeHouse
$51.62 /

+0.205 (+0.40%)

Downgrade
Bank of Montreal downgraded to Sector Perform from Outperform at National Bank » 20:36
05/27/20
05/27
20:36
05/27/20
20:36
BMO

Bank of Montreal

$51.67 /

+0.92 (+1.81%)

National Bank analyst…

National Bank analyst Gabriel Dechaine downgraded Bank of Montreal to Sector Perform from Outperform with a C$75 price target.

ShowHide Related Items >><<
BMO Bank of Montreal
$51.67 /

+0.92 (+1.81%)

BMO Bank of Montreal
$51.67 /

+0.92 (+1.81%)

05/22/20 Scotiabank
Bank of Montreal price target lowered to C$73 from C$82 at Scotiabank
04/28/20 TD Securities
Bank of Montreal downgraded to Buy on outperformance at TD Securities
04/28/20 TD Securities
Bank of Montreal downgraded to Buy from Action List Buy at TD Securities
03/20/20 TD Securities
Bank of Montreal upgraded to Buy from Hold at TD Securities
BMO Bank of Montreal
$51.67 /

+0.92 (+1.81%)

BMO Bank of Montreal
$51.67 /

+0.92 (+1.81%)

Earnings
Notable companies reporting before tomorrow's open » 20:25
05/27/20
05/27
20:25
05/27/20
20:25
DG

Dollar General

$186.80 /

+6.41 (+3.55%)

, DLTR

Dollar Tree

$87.43 /

+2.26 (+2.65%)

, BURL

Burlington Stores

$210.31 /

+1.44 (+0.69%)

, SHOO

Steven Madden

$25.78 /

+1.23 (+5.01%)

, ANF

Abercrombie & Fitch

$13.08 /

+0.41 (+3.24%)

, TGI

Triumph Group

$8.18 /

+1.92 (+30.67%)

, LL

Lumber Liquidators

$9.53 /

+0.79 (+9.04%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Dollar General (DG), consensus $1.70... Dollar Tree (DLTR), consensus 91c... Burlington Stores (BURL), consensus ($1.03)... Steven Madden (SHOO), consensus 20c... Abercrombie & Fitch (ANF), consensus ($1.26)... Triumph Group (TGI), consensus 64c... Lumber Liquidators (LL), consensus 2c.

ShowHide Related Items >><<
TGI Triumph Group
$8.18 /

+1.92 (+30.67%)

SHOO Steven Madden
$25.78 /

+1.23 (+5.01%)

LL Lumber Liquidators
$9.53 /

+0.79 (+9.04%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DG Dollar General
$186.80 /

+6.41 (+3.55%)

BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

ANF Abercrombie & Fitch
$13.08 /

+0.41 (+3.24%)

DG Dollar General
$186.80 /

+6.41 (+3.55%)

05/26/20 Deutsche Bank
Dollar General price target raised to $187 from $159 at Deutsche Bank
05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Goldman Sachs
Dollar General initiated with a Buy at Goldman Sachs
04/30/20
Fly Intel: Top five analyst downgrades
DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

05/26/20 Deutsche Bank
Dollar Tree price target raised to $97 from $87 at Deutsche Bank
05/18/20 Gordon Haskett
Colgate, Dollar Tree speculated as possible Peltz targets by Gordon Haskett
05/18/20 Goldman Sachs
Dollar Tree initiated with a Buy at Goldman Sachs
BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

05/11/20 Nomura Instinet
Burlington Stores price target raised to $190 from $170 at Nomura Instinet
03/24/20 Citi
Burlington Stores price target lowered to $205 from $260 at Citi
03/19/20 Nomura Instinet
Burlington Stores price target lowered to $170 from $252 at Nomura Instinet
03/11/20
Fly Intel: Top five analyst upgrades
SHOO Steven Madden
$25.78 /

+1.23 (+5.01%)

05/14/20
Fly Intel: Top five analyst downgrades
05/14/20 Wells Fargo
Wells Fargo downgrades Steven Madden to Underweight on brand weakness
05/14/20 Wells Fargo
Steven Madden downgraded to Underweight from Equal Weight at Wells Fargo
05/13/20 Loop Capital
Steven Madden downgraded to Hold from Buy at Loop Capital
ANF Abercrombie & Fitch
$13.08 /

+0.41 (+3.24%)

04/03/20
Fly Intel: Top five analyst upgrades
04/03/20 B. Riley FBR
B. Riley FBR upgrades Abercrombie on ability to 'weather the storm'
04/03/20 B. Riley FBR
Abercrombie & Fitch upgraded to Buy from Neutral at B. Riley FBR
03/24/20 Wedbush
Microsoft, Alphabet among stocks in Wedbush's Shopping List
TGI Triumph Group
$8.18 /

+1.92 (+30.67%)

03/20/20 BofA
BofA double downgrades Triumph, slashes price target amid COVID-19 impact
03/20/20 BofA
Triumph Group downgraded to Underperform from Buy at BofA
03/11/20 Goldman Sachs
Goldman cuts targets across Aerospace coverage for COVID-19 impact
08/23/19
Fly Intel: Top five analyst downgrades
LL Lumber Liquidators
$9.53 /

+0.79 (+9.04%)

01/21/20
Fly Intel: Top five analyst downgrades
01/21/20 Morgan Stanley
Lumber Liquidators downgraded to Underweight from Equal Weight at Morgan Stanley
12/04/19 Wedbush
Floor & Decor to see earnings boost from tariff exclusion, says Wedbush
09/13/19 Raymond James
Lumber Liquidators price target raised to $14 from $10 at Raymond James
SHOO Steven Madden
$25.78 /

+1.23 (+5.01%)

LL Lumber Liquidators
$9.53 /

+0.79 (+9.04%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DG Dollar General
$186.80 /

+6.41 (+3.55%)

BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

ANF Abercrombie & Fitch
$13.08 /

+0.41 (+3.24%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DG Dollar General
$186.80 /

+6.41 (+3.55%)

ANF Abercrombie & Fitch
$13.08 /

+0.41 (+3.24%)

LL Lumber Liquidators
$9.53 /

+0.79 (+9.04%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DG Dollar General
$186.80 /

+6.41 (+3.55%)

BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

ANF Abercrombie & Fitch
$13.08 /

+0.41 (+3.24%)

LL Lumber Liquidators
$9.53 /

+0.79 (+9.04%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DG Dollar General
$186.80 /

+6.41 (+3.55%)

BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

ANF Abercrombie & Fitch
$13.08 /

+0.41 (+3.24%)

Upgrade
Helmerich & Payne upgraded to Overweight from Neutral at Piper Sandler » 19:55
05/27/20
05/27
19:55
05/27/20
19:55
HP

Helmerich & Payne

$19.62 /

+0.19 (+0.98%)

Piper Sandler analyst Ian…

Piper Sandler analyst Ian Macpherson upgraded Helmerich & Payne to Overweight from Neutral with a $25 price target.

ShowHide Related Items >><<
HP Helmerich & Payne
$19.62 /

+0.19 (+0.98%)

HP Helmerich & Payne
$19.62 /

+0.19 (+0.98%)

04/13/20 Scotiabank
Helmerich & Payne downgraded to Sector Perform from Outperform at Scotiabank
04/05/20 Bernstein
Helmerich & Payne upgraded to Outperform from Market Perform at Bernstein
04/01/20 RBC Capital
Helmerich & Payne price target lowered to $25 from $30 at RBC Capital
03/20/20 Credit Suisse
Helmerich & Payne upgraded to Outperform from Neutral at Credit Suisse
HP Helmerich & Payne
$19.62 /

+0.19 (+0.98%)

HP Helmerich & Payne
$19.62 /

+0.19 (+0.98%)

HP Helmerich & Payne
$19.62 /

+0.19 (+0.98%)

Hot Stocks
Logitech announces new $250M stock buyback, raises dividend 10% » 19:53
05/27/20
05/27
19:53
05/27/20
19:53
LOGI

Logitech

$54.82 /

-1.68 (-2.97%)

Logitech board of…

Logitech board of directors has approved a new, three-year share buyback program, which authorizes the company to use up to $250M to repurchase its shares. The new program is expected to begin following approval from the Swiss Takeover Board and replaces the company's prior buyback program that expired in April 2020. Logitech's board of directors has also approved a proposal for a FY20 dividend, which would be approximately a 10% annual increase versus last year's dividend.

ShowHide Related Items >><<
LOGI Logitech
$54.82 /

-1.68 (-2.97%)

LOGI Logitech
$54.82 /

-1.68 (-2.97%)

05/21/20
Fly Intel: Top five analyst downgrades
05/21/20 JPMorgan
Logitech downgraded to Neutral on valuation at JPMorgan
05/21/20 JPMorgan
Logitech downgraded to Neutral from Overweight at JPMorgan
05/20/20
Fly Intel: Top five analyst upgrades
LOGI Logitech
$54.82 /

-1.68 (-2.97%)

LOGI Logitech
$54.82 /

-1.68 (-2.97%)

LOGI Logitech
$54.82 /

-1.68 (-2.97%)

Recommendations
Abiomed investor meeting offered positive data points, says Piper Sandler » 19:47
05/27/20
05/27
19:47
05/27/20
19:47
ABMD

Abiomed

$207.77 /

-1.44 (-0.69%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien keeps his Overweight rating and $225 price target on Abiomed after the company held an investor meeting with commentary from a number of physicians earlier today. The analyst notes the discussion contained favorable mortality and ancillary benefits from Impella, adding that further data should drive more adoption in the high-risk percutaneous coronary intervention group, along with more severe heart failure cases expected due to COVID.

ShowHide Related Items >><<
ABMD Abiomed
$207.77 /

-1.44 (-0.69%)

ABMD Abiomed
$207.77 /

-1.44 (-0.69%)

05/12/20 Piper Sandler
CMS again proposes cut to Abiomed key code, says Piper Sandler
04/30/20 Piper Sandler
Abiomed Q4 sales were beating before virus hit volumes, says Piper Sandler
04/28/20 Piper Sandler
Untreated heart attacks negative for Abiomed, says Piper Sandler
04/27/20 SVB Leerink
Abiomed downgraded to Market Perform at SVB Leerink
ABMD Abiomed
$207.77 /

-1.44 (-0.69%)

ABMD Abiomed
$207.77 /

-1.44 (-0.69%)

Recommendations
Piper Sandler positive on Itamar's tailwinds, salesforce expansion » 19:40
05/27/20
05/27
19:40
05/27/20
19:40
ITMR

Itamar Medical

$16.00 /

+0.17 (+1.07%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien keeps his Overweight rating and $22 price target on Itamar Medical after its Q1 results today. The analyst cites the management's confidence in the strong demand for its new disposable sleep testing product WatchPAT ONE given the COVID-related restrictions lowering sleep center throughput. O'Brien adds that given the increased use of disposable at-home testing, as well as Itamar's ample cash to focus on salesforce expansion, the outlook for the stock is bright.

ShowHide Related Items >><<
ITMR Itamar Medical
$16.00 /

+0.17 (+1.07%)

ITMR Itamar Medical
$16.00 /

+0.17 (+1.07%)

04/14/20 Alliance Global Partners
Itamar Medical price target lowered to $17.75 from $19.50
04/13/20 Piper Sandler
Piper remains constructive on Itamar outlook once pandemic is resolved
03/31/20
Fly Intel: Top five analyst initiations
03/31/20 Cowen
Itamar Medical initiated with an Outperform at Cowen
ITMR Itamar Medical
$16.00 /

+0.17 (+1.07%)

Initiation
Greggs initiated with a Buy at Jefferies » 19:34
05/27/20
05/27
19:34
05/27/20
19:34
GGGSF

Greggs

$0.00 /

+ (+0.00%)

Jefferies analyst Andrew…

Jefferies analyst Andrew Wade initiated coverage of Greggs with a Buy rating and 2,375 GBp price target. The company has built an "enviable long-term growth record", the analyst tells investors in a research note, and even though its FY20-FY21 will be impacted by COVID-19, a full recovery and a robust growth are anticipated thereafter. With the stock down 22% since mid-February, Wade believes that the current valuation of 18-times his expected FY22 estimates marks an "excellent opportunity" for investors.

ShowHide Related Items >><<
GGGSF Greggs
$0.00 /

+ (+0.00%)

05/19/20 Berenberg
Greggs upgraded to Buy from Hold at Berenberg
05/19/20 Berenberg
Greggs upgraded to Buy from Hold at Berenberg
08/28/19 UBS
Greggs upgraded to Buy from Neutral at UBS
Periodicals
Apple buys machine-learning startup Inductiv, Bloomberg reports » 19:15
05/27/20
05/27
19:15
05/27/20
19:15
AAPL

Apple

$318.11 /

+1.4 (+0.44%)

Apple has acquired…

Apple has acquired machine-learning startup Inductiv, add to more than a dozen AI-related takeovers by the tech giant over the past few years, Bloomberg's Mark Gurman reports. Apple confirmed the purchase, saying it "buys smaller technology companies from time to time and we generally do not discuss our purpose or plans," Gurman says. Reference Link

ShowHide Related Items >><<
AAPL Apple
$318.11 /

+1.4 (+0.44%)

AAPL Apple
$318.11 /

+1.4 (+0.44%)

05/27/20 BofA
Apple price target raised to $340 from $320 at BofA
05/27/20 Jefferies
Apple price target raised to $370 from $350 at Jefferies
05/27/20 Deutsche Bank
Apple price target raised to $320 from $305 at Deutsche Bank
05/26/20 Stifel
Cirrus Logic price target raised to $82 from $80 at Stifel
AAPL Apple
$318.11 /

+1.4 (+0.44%)

AAPL Apple
$318.11 /

+1.4 (+0.44%)

AAPL Apple
$318.11 /

+1.4 (+0.44%)

AAPL Apple
$318.11 /

+1.4 (+0.44%)

AAPL Apple
$318.11 /

+1.4 (+0.44%)

Periodicals
Marathon Partners to initiate proxy battle with e.l.f. Beauty, WSJ reports » 19:12
05/27/20
05/27
19:12
05/27/20
19:12
ELF

e.l.f. Beauty

$17.29 /

+0.6 (+3.59%)

Marathon Partners Equity…

Marathon Partners Equity Management intends to nominate three directors to the board of e.l.f. Beauty, a rare instance of an activist investor initiating a proxy battle since the COVID-19 crisis shook U.S. corporations, the Wall Street Journal's Corrie Driebusch reports. In a document viewed by the Journal, Marathon criticizes the cosmetic company's cost structure, management compensation plan, and stock performance. The activist's nominations to the board could be made public as soon as Thursday, Driebusch notes. Marathon, which has been an e.l.f. stakeholder since 2018, owns roughly 5% of the company's shares, the author says, citing people familiar with the matter. Reference Link

ShowHide Related Items >><<
ELF e.l.f. Beauty
$17.29 /

+0.6 (+3.59%)

ELF e.l.f. Beauty
$17.29 /

+0.6 (+3.59%)

05/22/20 SunTrust
e.l.f. Beauty price target raised to $20 from $15 at SunTrust
04/08/20 Piper Sandler
Piper lays out winners and losers in survey of 5,200 teens
03/18/20 DA Davidson
e.l.f. Beauty price target lowered to $12 from $24.50 at DA Davidson
02/06/20 Piper Sandler
e.l.f. Beauty price target raised to $23 from $19 at Piper Sandler
ELF e.l.f. Beauty
$17.29 /

+0.6 (+3.59%)

ELF e.l.f. Beauty
$17.29 /

+0.6 (+3.59%)

On The Fly
Fly Intel: After-Hours Movers » 19:08
05/27/20
05/27
19:08
05/27/20
19:08
NTNX

Nutanix

$24.94 /

+0.53 (+2.17%)

, COHR

Coherent

$149.11 /

+3.8 (+2.62%)

, HPQ

HP Inc.

$17.13 /

+0.06 (+0.35%)

, NTAP

NetApp

$46.30 /

+1.23 (+2.73%)

, ADSK

Autodesk

$199.71 /

+0.28 (+0.14%)

, HTZ

Hertz

$1.31 /

+0.7199 (+122.00%)

, IOVA

Iovance Biotherapeutics

$38.12 /

+0.66 (+1.76%)

, ARNA

Arena Pharmaceuticals

$58.07 /

+1.16 (+2.04%)

, CRNC

Cerence

$33.05 /

+0.47 (+1.44%)

, BCRX

BioCryst

$5.03 /

-0.17 (-3.27%)

, IMMU

Immunomedics

$34.18 /

+0.1 (+0.29%)

, PEN

Penumbra

$170.74 /

+1.29 (+0.76%)

, TWTR

Twitter

$33.06 /

-0.96 (-2.82%)

, PLT

Plantronics

$14.66 /

+0.67 (+4.79%)

, IMAB

I-MAB

$23.87 /

+0.665 (+2.87%)

, BA

Boeing

$149.46 /

+4.77 (+3.30%)

, HPP

Hudson Pacific

$24.18 /

+1.06 (+4.59%)

, DHC

Diversified Healthcare Trust

$3.23 /

+0.03 (+0.94%)

, PLMR

Palomar

$65.68 /

+2.57 (+4.07%)

, PHAS

PhaseBio

$4.42 /

-0.03 (-0.67%)

, SPTN

SpartanNash

$20.57 /

-0.02 (-0.10%)

, WDAY

Workday

$170.10 /

+1.72 (+1.02%)

, TOL

Toll Brothers

$32.95 /

+2.835 (+9.42%)

, BGFV

Big 5 Sporting

$1.94 /

+0.06 (+3.19%)

, SMTC

Semtech

$50.13 /

+1.18 (+2.41%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
WDAY Workday
$170.10 /

+1.72 (+1.02%)

TWTR Twitter
$33.06 /

-0.96 (-2.82%)

TOL Toll Brothers
$32.95 /

+2.835 (+9.42%)

SPTN SpartanNash
$20.57 /

-0.02 (-0.10%)

SMTC Semtech
$50.13 /

+1.18 (+2.41%)

PLT Plantronics
$14.66 /

+0.67 (+4.79%)

PLMR Palomar
$65.68 /

+2.57 (+4.07%)

PHAS PhaseBio
$4.42 /

-0.03 (-0.67%)

PEN Penumbra
$170.74 /

+1.29 (+0.76%)

NTNX Nutanix
$24.94 /

+0.53 (+2.17%)

NTAP NetApp
$46.30 /

+1.23 (+2.73%)

IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

IMAB I-MAB
$23.87 /

+0.665 (+2.87%)

HTZ Hertz
$1.31 /

+0.7199 (+122.00%)

HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

HPP Hudson Pacific
$24.18 /

+1.06 (+4.59%)

DHC Diversified Healthcare Trust
$3.23 /

+0.03 (+0.94%)

CRNC Cerence
$33.05 /

+0.47 (+1.44%)

COHR Coherent
$149.11 /

+3.8 (+2.62%)

BGFV Big 5 Sporting
$1.94 /

+0.06 (+3.19%)

BCRX BioCryst
$5.03 /

-0.17 (-3.27%)

BA Boeing
$149.46 /

+4.77 (+3.30%)

ARNA Arena Pharmaceuticals
$58.07 /

+1.16 (+2.04%)

ADSK Autodesk
$199.71 /

+0.28 (+0.14%)

NTNX Nutanix
$24.94 /

+0.53 (+2.17%)

05/21/20 JPMorgan
Nutanix price target lowered to $24 from $27 at JPMorgan
05/19/20 OTR Global
Nutanix downgraded to Mixed from Positive at OTR Global
04/27/20 Needham
Nutanix price target lowered to $24 from $42 at Needham
04/23/20 Cleveland Research
Nutanix trends in April softened versus prior months, says Cleveland Research
COHR Coherent
$149.11 /

+3.8 (+2.62%)

04/23/20 Goldman Sachs
Coherent upgraded to Buy from Neutral at Goldman Sachs
02/10/20
Fly Intel: Top five analyst initiations
02/10/20 Stifel
Coherent transferred with a Buy, $178 price target at Stifel
02/06/20 Piper Sandler
Coherent price target lowered to $195 from $205 at Piper Sandler
HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

05/26/20 Credit Suisse
HP Inc. price target lowered to $17 from $22 at Credit Suisse
05/22/20 JPMorgan
HP shares worth owning through downturn, says JPMorgan
04/27/20 Loop Capital
Xerox, Park City, NetApp, HP Enterprise cut to Hold from Buy at Loop Capital
04/21/20 Deutsche Bank
HP Inc. price target lowered to $17 from $20 at Deutsche Bank
NTAP NetApp
$46.30 /

+1.23 (+2.73%)

05/19/20 Barclays
Barclays lowers estimates in IT hardware after April survey
05/11/20
Fly Intel: Top five analyst downgrades
05/11/20 Stifel
NetApp downgraded to Hold from Buy at Stifel
ADSK Autodesk
$199.71 /

+0.28 (+0.14%)

05/22/20 Deutsche Bank
Autodesk price target lowered to $215 from $230 at Deutsche Bank
05/21/20 Citi
Citi sees difficult setup for Autodesk into results, cuts price target
05/19/20 KeyBanc
Autodesk price target raised to $210 from $200 at KeyBanc
05/07/20 OTR Global
Autodesk downgraded to Mixed from Positive at OTR Global
HTZ Hertz
$1.31 /

+0.7199 (+122.00%)

05/05/20 Morgan Stanley
2020 may not be quite as bad as feared for used cars, says Morgan Stanley
04/27/20
Fly Intel: Top five analyst downgrades
04/27/20 Barclays
Barclays downgrades Hertz to Underweight on risk of capital call
04/27/20 Barclays
Hertz downgraded to Underweight from Equal Weight at Barclays
IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

04/29/20 Oppenheimer
Iovance Biotherapeutics price target raised to $43 from $35 at Oppenheimer
04/29/20 H.C. Wainwright
Iovance Biotherapeutics price target raised to $48 from $36 at H.C. Wainwright
04/27/20 Piper Sandler
AACR abstract for Moffitt study positive for Iovance, says Piper Sandler
04/22/20 Piper Sandler
AACR meeting should bring more support for Iovance TILs, says Piper Sandler
ARNA Arena Pharmaceuticals
$58.07 /

+1.16 (+2.04%)

05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Jefferies
Arena Pharmaceuticals initiated with a Buy at Jefferies
05/18/20 Jefferies
Arena Pharmaceuticals initiated with a Buy at Jefferies
03/31/20 Guggenheim
Guggenheim starts Arena at Buy on 'pipeline-in-a-product' etrasimod
CRNC Cerence
$33.05 /

+0.47 (+1.44%)

05/27/20 Wedbush
Cerence price target raised to $40 from $27 at Wedbush
05/26/20 Raymond James
Cerence downgraded to Outperform from Strong Buy at Raymond James
05/26/20 Raymond James
Cerence downgraded to Outperform from Strong Buy at Raymond James
05/12/20
Fly Intel: Top five analyst initiations
BCRX BioCryst
$5.03 /

-0.17 (-3.27%)

05/06/20 JMP Securities
BioCryst has potential best-in-class PNH treatment, says JMP Securities
05/06/20 Piper Sandler
BioCryst price target raised to $10 from $8 at Piper Sandler
05/05/20 Barclays
BioCryst upgraded to Overweight from Equal Weight at Barclays
04/29/20 JMP Securities
Positive remdesivir news 'bodes well' for BioCryst, says JMP Securities
IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

05/06/20 Piper Sandler
Immunomedics well positioned to execute on Trodelvy launch, says Piper Sandler
05/05/20 Barclays
Immunomedics initiated with an Overweight, $40 target at Barclays
05/04/20 Barclays
Immunomedics initiated with an Overweight at Barclays
04/24/20
Fly Intel: Top five analyst upgrades
PEN Penumbra
$170.74 /

+1.29 (+0.76%)

05/08/20 Citi
Penumbra price target raised to $214 from $192 at Citi
03/04/20 Citi
Penumbra initiated with a Buy at Citi
03/02/20 Wells Fargo
Baxter, J&J best positioned to weather coronavirus spread, says Wells Fargo
02/26/20 Canaccord
Penumbra weakness buying opportunity, says Canaccord
TWTR Twitter
$33.06 /

-0.96 (-2.82%)

05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/06/20 China Renaissance
Twitter price target lowered to $23 from $25 at China Renaissance
05/01/20
Fly Intel: Top five analyst downgrades
05/01/20 Deutsche Bank
Twitter price target raised to $28 from $22 at Deutsche Bank
PLT Plantronics
$14.66 /

+0.67 (+4.79%)

04/16/20 Morgan Stanley
Morgan Stanley cuts Plantronics to Underweight citing upcoming challenges
04/16/20 Morgan Stanley
Plantronics downgraded to Underweight from Equal Weight at Morgan Stanley
03/30/20 JPMorgan
Plantronics downgraded to Underweight from Neutral at JPMorgan
03/30/20 JPMorgan
Plantronics downgraded to Underweight from Neutral at JPMorgan
IMAB I-MAB
$23.87 /

+0.665 (+2.87%)

02/14/20
Fly Intel: Top five analyst initiations
02/13/20 CICC
I-MAB initiated with an Outperform at CICC
02/12/20
Fly Intel: Top five analyst initiations
02/11/20 China Renaissance
I-MAB initiated with a Buy at China Renaissance
BA Boeing
$149.46 /

+4.77 (+3.30%)

05/22/20 Canaccord
Boeing price target lowered to $155 from $175 at Canaccord
05/20/20 RBC Capital
RBC starts Boeing at Outperform on favorable risk/reward profile
05/20/20 RBC Capital
Boeing initiated with an Outperform at RBC Capital
05/05/20 Nord/LB
Boeing downgraded to Sell from Hold at Nord/LB
HPP Hudson Pacific
$24.18 /

+1.06 (+4.59%)

04/16/20 Jefferies
Hudson Pacific initiated with a Hold at Jefferies
02/04/20 Mizuho
Hudson Pacific assumed with a Buy at Mizuho
01/15/20 Mizuho
Hudson Pacific upgraded to Buy from Neutral at Mizuho
11/08/19 Goldman Sachs
Hudson Pacific initiated with a Buy at Goldman Sachs
DHC Diversified Healthcare Trust
$3.23 /

+0.03 (+0.94%)

05/19/20 RBC Capital
Diversified Healthcare Trust price target lowered to $3 from $7 at RBC Capital
03/11/20 Mizuho
Sabra Health Care to be pressured by coronavirus at facility, says Mizuho
01/16/20 Wells Fargo
Diversified Healthcare Trust cut to Equal Weight from Overweight at Wells Fargo
01/07/20 Raymond James
Healthcare REIT sector downgraded to Market Weight at Raymond James
PLMR Palomar
$65.68 /

+2.57 (+4.07%)

01/14/20 JMP Securities
Palomar price target raised to $55 from $50 at JMP Securities
01/10/20 Keefe Bruyette
Palomar target raised to $58 after share offering at Keefe Bruyette
12/16/19 William Blair
Palomar should be bought despite recent rally, says William Blair
12/08/19 Keefe Bruyette
Palomar price target raised to $57 from $48 at Keefe Bruyette
PHAS PhaseBio
$4.42 /

-0.03 (-0.67%)

05/07/20 Stifel
Portola deal highlights value of PhaseBio's PB2452, says Stifel
04/06/20 Citi
PhaseBio price target lowered to $11 from $25 at Citi
01/27/20 William Blair
PhaseBio could see increase to PB2452 addressable market, says William Blair
01/16/20 Stifel
PhaseBio acquisition of PB6440 an 'excellent' strategic move, says Stifel
SPTN SpartanNash
$20.57 /

-0.02 (-0.10%)

03/19/20 Barclays
SpartanNash upgraded to Equal Weight from Underweight at Barclays
03/18/20 BMO Capital
SpartanNash upgraded to Market Perform from Underperform at BMO Capital
10/04/19
SpartanNash management to meet with Loop Capital
WDAY Workday
$170.10 /

+1.72 (+1.02%)

05/21/20 OTR Global
Workday downgraded to Mixed from Positive at OTR Global
05/18/20
Fly Intel: Top five analyst downgrades
05/18/20 Cleveland Research
Workday downgraded to Neutral from Buy at Cleveland Research
05/18/20 RBC Capital
Workday price target lowered to $194 from $230 at RBC Capital
TOL Toll Brothers
$32.95 /

+2.835 (+9.42%)

05/27/20 Credit Suisse
Toll Brothers initiated with a Neutral at Credit Suisse
05/27/20 Credit Suisse
KB Home initiated with an Outperform at Credit Suisse
05/11/20 Wedbush
Toll Brothers price target lowered to $35 from $48 at Wedbush
05/04/20 Evercore ISI
Toll Brothers upgraded to In Line from Underperform at Evercore ISI
BGFV Big 5 Sporting
$1.94 /

+0.06 (+3.19%)

SMTC Semtech
$50.13 /

+1.18 (+2.41%)

03/12/20 Susquehanna
Semtech results inline and guidance better than feared, says Susquehanna
03/12/20 Loop Capital
Semtech price target lowered to $46 from $56 at Loop Capital
03/12/20 B. Riley FBR
Semtech price target lowered to $50 from $55 at B. Riley FBR
03/12/20 Needham
Semtech upgraded to Buy from Hold at Needham
WDAY Workday
$170.10 /

+1.72 (+1.02%)

TWTR Twitter
$33.06 /

-0.96 (-2.82%)

TOL Toll Brothers
$32.95 /

+2.835 (+9.42%)

SPTN SpartanNash
$20.57 /

-0.02 (-0.10%)

SMTC Semtech
$50.13 /

+1.18 (+2.41%)

PLT Plantronics
$14.66 /

+0.67 (+4.79%)

PLMR Palomar
$65.68 /

+2.57 (+4.07%)

PHAS PhaseBio
$4.42 /

-0.03 (-0.67%)

PEN Penumbra
$170.74 /

+1.29 (+0.76%)

NTNX Nutanix
$24.94 /

+0.53 (+2.17%)

NTAP NetApp
$46.30 /

+1.23 (+2.73%)

IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

IMAB I-MAB
$23.87 /

+0.665 (+2.87%)

HTZ Hertz
$1.31 /

+0.7199 (+122.00%)

HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

HPP Hudson Pacific
$24.18 /

+1.06 (+4.59%)

DHC Diversified Healthcare Trust
$3.23 /

+0.03 (+0.94%)

CRNC Cerence
$33.05 /

+0.47 (+1.44%)

COHR Coherent
$149.11 /

+3.8 (+2.62%)

BGFV Big 5 Sporting
$1.94 /

+0.06 (+3.19%)

BCRX BioCryst
$5.03 /

-0.17 (-3.27%)

BA Boeing
$149.46 /

+4.77 (+3.30%)

ARNA Arena Pharmaceuticals
$58.07 /

+1.16 (+2.04%)

ADSK Autodesk
$199.71 /

+0.28 (+0.14%)

  • 29
    May
  • 28
    May
  • 29
    May
  • 28
    May
TWTR Twitter
$33.06 /

-0.96 (-2.82%)

PLT Plantronics
$14.66 /

+0.67 (+4.79%)

NTNX Nutanix
$24.94 /

+0.53 (+2.17%)

IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

HTZ Hertz
$1.31 /

+0.7199 (+122.00%)

HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

HPP Hudson Pacific
$24.18 /

+1.06 (+4.59%)

BA Boeing
$149.46 /

+4.77 (+3.30%)

ADSK Autodesk
$199.71 /

+0.28 (+0.14%)

WDAY Workday
$170.10 /

+1.72 (+1.02%)

TWTR Twitter
$33.06 /

-0.96 (-2.82%)

TOL Toll Brothers
$32.95 /

+2.835 (+9.42%)

PLT Plantronics
$14.66 /

+0.67 (+4.79%)

PLMR Palomar
$65.68 /

+2.57 (+4.07%)

PEN Penumbra
$170.74 /

+1.29 (+0.76%)

NTNX Nutanix
$24.94 /

+0.53 (+2.17%)

NTAP NetApp
$46.30 /

+1.23 (+2.73%)

IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

IMAB I-MAB
$23.87 /

+0.665 (+2.87%)

HTZ Hertz
$1.31 /

+0.7199 (+122.00%)

HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

CRNC Cerence
$33.05 /

+0.47 (+1.44%)

BCRX BioCryst
$5.03 /

-0.17 (-3.27%)

BA Boeing
$149.46 /

+4.77 (+3.30%)

ARNA Arena Pharmaceuticals
$58.07 /

+1.16 (+2.04%)

ADSK Autodesk
$199.71 /

+0.28 (+0.14%)

WDAY Workday
$170.10 /

+1.72 (+1.02%)

TWTR Twitter
$33.06 /

-0.96 (-2.82%)

TOL Toll Brothers
$32.95 /

+2.835 (+9.42%)

PLT Plantronics
$14.66 /

+0.67 (+4.79%)

PHAS PhaseBio
$4.42 /

-0.03 (-0.67%)

NTNX Nutanix
$24.94 /

+0.53 (+2.17%)

NTAP NetApp
$46.30 /

+1.23 (+2.73%)

IOVA Iovance Biotherapeutics
$38.12 /

+0.66 (+1.76%)

IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

HTZ Hertz
$1.31 /

+0.7199 (+122.00%)

HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

DHC Diversified Healthcare Trust
$3.23 /

+0.03 (+0.94%)

BCRX BioCryst
$5.03 /

-0.17 (-3.27%)

BA Boeing
$149.46 /

+4.77 (+3.30%)

ADSK Autodesk
$199.71 /

+0.28 (+0.14%)

Hot Stocks
Leidos awarded $84.6M payment from VirnetX suit against Apple » 18:50
05/27/20
05/27
18:50
05/27/20
18:50
LDOS

Leidos

$102.73 /

+0.44 (+0.43%)

, AAPL

Apple

$318.11 /

+1.4 (+0.44%)

Leidos (LDOS) announced…

Leidos (LDOS) announced that it has received $84.6M from VirnetX representing Leidos' current share of the proceeds resulting from the VirnetX, Inc. lawsuit against Apple (AAPL) for infringing VirnetX patents. Leidos expects to use some of the proceeds from the patent litigation to recover its costs of the litigation and to pay a royalty to the customer who paid for the development of the technology. Leidos intends to use the remainder of the proceeds for debt reduction. The final judgment in the case remains subject to ongoing and potential future proceedings and appeals and Apple has indicated that it will seek restitution of its payment to VirnetX if relief is awarded. A second case by VirnetX against Apple is still pending at the federal trial court in the Eastern District of Texas.

ShowHide Related Items >><<
LDOS Leidos
$102.73 /

+0.44 (+0.43%)

AAPL Apple
$318.11 /

+1.4 (+0.44%)

LDOS Leidos
$102.73 /

+0.44 (+0.43%)

05/07/20
Fly Intel: Top five analyst initiations
05/07/20 Credit Suisse
Leidos reinstated with an Outperform at Credit Suisse
05/04/20 Wells Fargo
Leidos price target raised to $114 from $105 at Wells Fargo
04/20/20 Citi
Leidos upgraded to Buy from Neutral at Citi
AAPL Apple
$318.11 /

+1.4 (+0.44%)

05/27/20 BofA
Apple price target raised to $340 from $320 at BofA
05/27/20 Jefferies
Apple price target raised to $370 from $350 at Jefferies
05/27/20 Deutsche Bank
Apple price target raised to $320 from $305 at Deutsche Bank
05/26/20 Stifel
Cirrus Logic price target raised to $82 from $80 at Stifel
LDOS Leidos
$102.73 /

+0.44 (+0.43%)

AAPL Apple
$318.11 /

+1.4 (+0.44%)

LDOS Leidos
$102.73 /

+0.44 (+0.43%)

AAPL Apple
$318.11 /

+1.4 (+0.44%)

LDOS Leidos
$102.73 /

+0.44 (+0.43%)

AAPL Apple
$318.11 /

+1.4 (+0.44%)

AAPL Apple
$318.11 /

+1.4 (+0.44%)

AAPL Apple
$318.11 /

+1.4 (+0.44%)

Hot Stocks
Jazz Pharmaceuticals board member buys 50K shares of common stock » 18:40
05/27/20
05/27
18:40
05/27/20
18:40
JAZZ

Jazz Pharmaceuticals

$113.38 /

+4.03 (+3.69%)

In a regulatory filing,…

In a regulatory filing, Jazz Pharmaceuticals disclosed that its board member Seamus Mulligan bought 50K shares of common stock on May 25th-26th in a total transaction size of $5.55M.

ShowHide Related Items >><<
JAZZ Jazz Pharmaceuticals
$113.38 /

+4.03 (+3.69%)

JAZZ Jazz Pharmaceuticals
$113.38 /

+4.03 (+3.69%)

05/06/20 SVB Leerink
Jazz Pharmaceuticals price target lowered to $160 from $169 at SVB Leerink
05/06/20 Oppenheimer
Jazz Pharmaceuticals price target lowered to $132 from $141 at Oppenheimer
05/06/20 BMO Capital
Jazz Pharmaceuticals price target lowered to $193 from $205 at BMO Capital
05/06/20 Piper Sandler
Jazz Pharmaceuticals price target lowered to $113 from $127 at Piper Sandler
JAZZ Jazz Pharmaceuticals
$113.38 /

+4.03 (+3.69%)

JAZZ Jazz Pharmaceuticals
$113.38 /

+4.03 (+3.69%)

Hot Stocks
Huntington Ingalls' Green sells 3,194 common shares » 18:30
05/27/20
05/27
18:30
05/27/20
18:30
HII

Huntington Ingalls

$205.82 /

+12.77 (+6.61%)

In a regulatory filing,…

In a regulatory filing, Huntington Ingalls executive VP Edgar A. Green III disclosed the sale of 3,194 common shares of the company on May 26 at a price of $191.59 per share.

ShowHide Related Items >><<
HII Huntington Ingalls
$205.82 /

+12.77 (+6.61%)

HII Huntington Ingalls
$205.82 /

+12.77 (+6.61%)

05/22/20
Fly Intel: Top five analyst upgrades
05/21/20 Stifel
Huntington Ingalls upgraded to Hold from Sell at Stifel
05/20/20 RBC Capital
RBC starts 'top value investment' Huntington Ingalls with Outperform
05/20/20 RBC Capital
Huntington Ingalls initiated with an Outperform at RBC Capital
HII Huntington Ingalls
$205.82 /

+12.77 (+6.61%)

HII Huntington Ingalls
$205.82 /

+12.77 (+6.61%)

HII Huntington Ingalls
$205.82 /

+12.77 (+6.61%)

Hot Stocks
Arizona AG files consumer fraud lawsuit against Google » 18:26
05/27/20
05/27
18:26
05/27/20
18:26
GOOG

Alphabet

$1,418.57 /

+0.64 (+0.05%)

, GOOGL

Alphabet Class A

$1,420.39 /

-1.32 (-0.09%)

Arizona Attorney General…

Arizona Attorney General Mark Brnovich said via Twitter: "Today we filed a consumer fraud lawsuit against Google for deceptive and unfair practices used to obtain users' location data, which Google then exploits for its lucrative advertising business." Reference Link

ShowHide Related Items >><<
GOOGL Alphabet Class A
$1,420.39 /

-1.32 (-0.09%)

GOOG Alphabet
$1,418.57 /

+0.64 (+0.05%)

GOOG Alphabet
$1,418.57 /

+0.64 (+0.05%)

05/27/20 Morgan Stanley
Amazon deal could open door for ridesharing competition, says Morgan Stanley
05/12/20 Citi
Alphabet price target raised to $1,600 from $1,400 at Citi
05/07/20 Credit Suisse
YouTube TV deal 'the big news' from ViacomCBS report, says Credit Suisse
05/07/20 Bernstein
Google payments to Apple big, predicated on advertising, says Bernstein
GOOGL Alphabet Class A
$1,420.39 /

-1.32 (-0.09%)

GOOG Alphabet
$1,418.57 /

+0.64 (+0.05%)

GOOG Alphabet
$1,418.57 /

+0.64 (+0.05%)

GOOG Alphabet
$1,418.57 /

+0.64 (+0.05%)

GOOGL Alphabet Class A
$1,420.39 /

-1.32 (-0.09%)

GOOG Alphabet
$1,418.57 /

+0.64 (+0.05%)

GOOGL Alphabet Class A
$1,420.39 /

-1.32 (-0.09%)

GOOG Alphabet
$1,418.57 /

+0.64 (+0.05%)

Hot Stocks
HP Inc. CEO: We had some supply chain issues in Q2 » 18:23
05/27/20
05/27
18:23
05/27/20
18:23
HPQ

HP Inc.

$17.13 /

+0.06 (+0.35%)

In an interview on…

In an interview on CNBC's Mad Money, Enrique Lores said HP experienced some supply chain issues in Q2, notably in China. Despite that, demand for PCs in Q2 was strong. The company was almost at full capacity by the beginning of May, according to Lores. He noted HP will become more aggressive with share buybacks as the business situation stabilizes. He continues to think the stock is undervalued. Going forward, he views the work at home trend as an opportunity for both PC's and print.

ShowHide Related Items >><<
HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

05/26/20 Credit Suisse
HP Inc. price target lowered to $17 from $22 at Credit Suisse
05/22/20 JPMorgan
HP shares worth owning through downturn, says JPMorgan
04/27/20 Loop Capital
Xerox, Park City, NetApp, HP Enterprise cut to Hold from Buy at Loop Capital
04/21/20 Deutsche Bank
HP Inc. price target lowered to $17 from $20 at Deutsche Bank
HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

HPQ HP Inc.
$17.13 /

+0.06 (+0.35%)

Hot Stocks
SPDR Gold Shares holdings rise to 1,119.05MT from 1,116.71MT » 18:23
05/27/20
05/27
18:23
05/27/20
18:23
GLD

SPDR Gold Shares

$161.17 /

+0.31 (+0.19%)

This is the highest level…

This is the highest level of holdings since April of 2013.

ShowHide Related Items >><<
GLD SPDR Gold Shares
$161.17 /

+0.31 (+0.19%)

GLD SPDR Gold Shares
$161.17 /

+0.31 (+0.19%)

GLD SPDR Gold Shares
$161.17 /

+0.31 (+0.19%)

GLD SPDR Gold Shares
$161.17 /

+0.31 (+0.19%)

Periodicals
AstraZeneca tests Farxiga as COVID-19 treatment, Reuters reports » 18:10
05/27/20
05/27
18:10
05/27/20
18:10
AZN

AstraZeneca

$52.46 /

-0.645 (-1.21%)

AstraZeneca is testing…

AstraZeneca is testing one of its diabetes drugs, Farxiga, as a treatment for COVID-19, even as doctors are warning diabetes patients infected by the coronavirus to stop taking the medicine and others like it because of a potentially dangerous side effect, Reuters' Deborah Nelson and Chad Terhune report. The trial of 900 hospitalized patients, dubbed DARE-19, will test Farxiga against a placebo with results expected by December. The international study began in April. Reference Link

ShowHide Related Items >><<
AZN AstraZeneca
$52.46 /

-0.645 (-1.21%)

AZN AstraZeneca
$52.46 /

-0.645 (-1.21%)

05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
05/04/20 Citi
Citi opens 'positive catalyst watch' on AstraZeneca
05/01/20 Guggenheim
AstraZeneca price target raised to 9,100 GBp from 8,900 GBp at Guggenheim
AZN AstraZeneca
$52.46 /

-0.645 (-1.21%)

AZN AstraZeneca
$52.46 /

-0.645 (-1.21%)

AZN AstraZeneca
$52.46 /

-0.645 (-1.21%)

AZN AstraZeneca
$52.46 /

-0.645 (-1.21%)

Upgrade
DouYu upgraded to Overweight from Neutral at JPMorgan » 18:09
05/27/20
05/27
18:09
05/27/20
18:09
DOYU

DouYu

$8.13 /

-0.06 (-0.73%)

JPMorgan analyst Daniel…

JPMorgan analyst Daniel Chen upgraded DouYu International to Overweight from Neutral with an $11 price target. The analyst sees an improving financial outlook and views second half of 2020 new game launches as a key catalyst for the stock.

ShowHide Related Items >><<
DOYU DouYu
$8.13 /

-0.06 (-0.73%)

DOYU DouYu
$8.13 /

-0.06 (-0.73%)

12/05/19 Jefferies
DouYu initiated with a Buy at Jefferies
12/02/19 JPMorgan
DouYu downgraded to Neutral from Overweight at JPMorgan
12/02/19 Morgan Stanley
DouYu downgraded to Equal Weight from Overweight at Morgan Stanley
09/16/19 HSBC
DouYu initiated with a Hold at HSBC
DOYU DouYu
$8.13 /

-0.06 (-0.73%)

DOYU DouYu
$8.13 /

-0.06 (-0.73%)

Earnings
Best Inc. reports Q1 non-GAAP EPS (26c), consensus (17c) » 18:05
05/27/20
05/27
18:05
05/27/20
18:05
BEST

Best Inc.

$4.88 /

-0.18 (-3.56%)

Reports Q1 revenue…

Reports Q1 revenue $771.9M, consensus $884.04M. CEO Johnny Chou commented, "As we entered q2, all of our business lines had swiftly returned to normal operations, and I am pleased to report that the demand for our integrated supply chain and logistics services are robust as consumer purchasing habits have shifted deeper online. (...) Strategically, we continued to optimize our logistics networks during the quarter by further improving route planning and automation, integrating our comprehensive solutions to create revenue and cost synergies, and enhancing overall quality of service. In addition, we are exploring ways to sharpen our strategic focus, with one potential option being the spin-off of certain business units that are in early stages of development with the intent of moving the company to profitability while allowing those units to independently raise capital for future growth."

ShowHide Related Items >><<
BEST Best Inc.
$4.88 /

-0.18 (-3.56%)

05/15/20
Fly Intel: Top five analyst downgrades
05/15/20 Macquarie
Best Inc. downgraded to Neutral from Outperform at Macquarie
03/02/20 Oppenheimer
Best Inc. assumed with an Outperform at Oppenheimer
12/05/19 Jefferies
Best Inc. initiated with a Buy at Jefferies
Hot Stocks
CNS Pharmaceuticals to resume trading on Thursday May 28th » 18:01
05/27/20
05/27
18:01
05/27/20
18:01
CNSP

CNS Pharmaceuticals

$2.70 /

+ (+0.00%)

CNS Pharmaceuticals…

CNS Pharmaceuticals announced that it has received notification from Nasdaq that trading in the company's common stock will resume on Thursday, May 28, 2020.

ShowHide Related Items >><<
CNSP CNS Pharmaceuticals
$2.70 /

+ (+0.00%)

CNSP CNS Pharmaceuticals
$2.70 /

+ (+0.00%)

12/04/19 Benchmark
CNS Pharmaceuticals initiated with a Speculative Buy at Benchmark
Hot Stocks
Moleculin Biotech says common stock to resume trading on Nasdaq on May 28 » 17:55
05/27/20
05/27
17:55
05/27/20
17:55
MBRX

Moleculin Biotech

$1.06 /

+ (+0.00%)

Moleculin Biotech, Inc…

Moleculin Biotech, Inc announced that it has received notification from Nasdaq that trading in the company's common stock will resume on Thursday, May 28, 2020.

ShowHide Related Items >><<
MBRX Moleculin Biotech
$1.06 /

+ (+0.00%)

MBRX Moleculin Biotech
$1.06 /

+ (+0.00%)

04/08/20 Roth Capital
Moleculin can expedite COVID candidate amid less restrictions, says Roth Capital
10/17/19 Oppenheimer
Moleculin Biotech initiated with an Outperform at Oppenheimer
Periodicals
Nokia announces Sari Baldauf takes over as chairwoman, Reuters says » 17:54
05/27/20
05/27
17:54
05/27/20
17:54
NOK

Nokia

$3.92 /

+0.06 (+1.56%)

, ERIC

Ericsson

$8.78 /

-0.03 (-0.34%)

Finnish telecoms…

Finnish telecoms equipment maker Nokia (NOK) announced Sari Baldauf succeeded Risto Siilasmaa as chairperson of the company, wrote Tarmo Virki and Anne Kauranen of Reuters. "Baldauf, one of the most high-profile female executives in the global telecoms industry, faces a tough task to fight back in the 5G race, as rivals Ericsson (ERIC) and Huawei put pressure on its sales and cash reserves.," added the Reuters story. Reference Link

ShowHide Related Items >><<
NOK Nokia
$3.92 /

+0.06 (+1.56%)

ERIC Ericsson
$8.78 /

-0.03 (-0.34%)

NOK Nokia
$3.92 /

+0.06 (+1.56%)

05/05/20 Deutsche Bank
Nokia price target raised to EUR 4 from EUR 3.80 at Deutsche Bank
05/01/20 Credit Suisse
Credit Suisse cuts Nokia sales forecasts after Q1 results
03/27/20 Goldman Sachs
Nokia upgraded to Neutral from Sell at Goldman Sachs
03/02/20
Fly Intel: Top five analyst initiations
ERIC Ericsson
$8.78 /

-0.03 (-0.34%)

04/17/20 Credit Suisse
Ericsson price target raised to SEK 98 from SEK 97 at Credit Suisse
03/30/20 BofA
US 1 List changes at BofA
03/30/20 Cowen
Ericsson upgraded to Outperform from Market Perform at Cowen
03/27/20 Raymond James
Raymond James upgrades Ericsson with networking an essential service
NOK Nokia
$3.92 /

+0.06 (+1.56%)

ERIC Ericsson
$8.78 /

-0.03 (-0.34%)

NOK Nokia
$3.92 /

+0.06 (+1.56%)

ERIC Ericsson
$8.78 /

-0.03 (-0.34%)

NOK Nokia
$3.92 /

+0.06 (+1.56%)

ERIC Ericsson
$8.78 /

-0.03 (-0.34%)

NOK Nokia
$3.92 /

+0.06 (+1.56%)

ERIC Ericsson
$8.78 /

-0.03 (-0.34%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.